Eloxx Pharmaceuticals names T.R. Srinivas chief medical officer
ELOX•Eloxx Pharmaceuticals appointed a Novartis executive as senior vice president and chief medical officer to oversee renal medical strategy across its Alport and ADPKD programs.
1. Medical leadership appointment
Eloxx Pharmaceuticals appointed T.R. Srinivas, whose Novartis responsibilities included U.S. medical affairs leadership for ADPKD product development, as senior vice president and chief medical officer. He will oversee renal medical strategy across the Alport and ADPKD programs.
